Medicine
Epioxa Cross-linking kit
Epioxa Cross-linking kit is a prescription medicine containing Riboflavin 5-phosphate ophthalmic for ophthalmic use, marketed by Glaukos, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store kit refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.
Key facts
- Active ingredient (INN)
- Riboflavin 5-phosphate ophthalmic
- Brand
- Epioxa Cross-linking
- Dosage form
- Kit
- Route
- Ophthalmic
- Packs
- 1 kit
- Marketing authorisation holder
- Glaukos
- Manufacturer
- Glaukos
- Origin register
- US FDA, United States
- Storage
- Store kit refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 January 2026
- Identifiers
- RxCUI 2727363, 2727368, 2727371 +3DailyMed set ID 13cefc46-337c-41a3-b113-106bfe553bbbNDC 25357-024Application NDA219910
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 1 syringe, glass in 1 pouch / 2 mL in 1 syringe, glass * 1 syringe, glass in 1 pouch / 2 mL in 1 syringe, glass | 25357-024-01 | Glaukos | 16 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Riboflavin 5-phosphate ophthalmic kit.
Clinical summary
Riboflavin 5-phosphate ophthalmic is a prescription medicine indicated in corneal collagen cross-linking, among other approved uses. It is available as kits for ophthalmic use. MedsAcross supplies Riboflavin 5-phosphate ophthalmic for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Riboflavin 5-phosphate ophthalmicFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Photrexa Cross-linking Kit prescribing information (Glaukos) · U.S. National Library of Medicine, DailyMed
Need Epioxa Cross-linking kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.